Production of raw materials & products The largest manufacturer of oncology, cardiovascular & neurological drugs
The fourth largest producer in the country
The largest pharmaceutical holdings in the country Having more than 12% of Drug market share in Iran as a
Knowledge-based economic complex
14% share of the country's pharmaceutical market Alborz as specialized pharmaceutical investment holding company in the country
Has been able to gain a good position in the pharmaceutical industry

Alborz Investment

Alborz Investment Co. (Public Company) was primarily founded under the name of “Yekdel” on December, 24th, of 1966 with the registration No. 11168 in the Organization for Registration of Companies and Industrial Ownership of Tehran and then turned from public to private on October, 20th, 1971, and its name was amended to Yekdel Private Joint Stock Company. Consequently, in the extraordinary general meeting dated July, 25th, 1974, it was turned from Private Joint Stock Company to Public Company. The current name of this company is Alborz Investigation Co. (Public Company).

750 Type of Medicine
In 12 areas of treatment
% 14 Market share
Having 10 pharmaceutical companies
54 Years of experience
The second holding of the country


Alborz Investment Group

Having more than 12% of the drug market share in Iran as a knowledge-based economic complex